AlphaValue/Baader Europe on Wednesday upgraded pure-play biology company Novonesis (NSIS-B.CO) to add from a reduce rating and increased its price target to 511 Danish kroner from 475 kroner.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)